The main long-term complications of heart valve replacement are valve failure, myocardial failure, thromboembolism, and prosthetic endocarditis. With the exception of endocarditis these risks differ greatly with the prosthesis, the implantation site, and the original disease. Most mechanical valves have a good record of reliability,' 2 and tissue valves have a low risk of embolism3-6; but the durability of the latter7-9 and the embolic risks of the former10 remain major causes for concern.
congenital/degenerative origin is often associated with coronary artery disease, and this may lead to the presenting symptom being angina. Assessment is best made by preoperative coronary angiography; if necessary a coronary artery bypass may be done at the time of valve replacement. The results of aortic valve replacement for chronic aortic regurgitation are usually satisfactory despite some residual left ventricular dilatation and hypertrophy. Since, however, aortic regurgitation is an asymptomatic disorder until a late stage the timing of operation is difficult. '2 The operative mortality for elective replacement of the mitral valve and for multiple valve replacement tends to be at least 10%, and the long-term results are not as good as those of lone aortic valve replacement. Left ventricular function often remains poor after replacement of the mitral valve for chronic regurgitation, which suggests that patients might benefit from earlier operation,'3-1 but the paradox is that patients tend to be too fit until their ventricle becomes unfit.
The substantial operative mortality and the risks of wearing an artificial valve must be set against the years of reasonable activity that may be obtained if operation is deferred.
In chronic mitral regurgitation the left ventricle is dilated and thin-walled. Replacement best left alone unless it is very severe because it keeps the left atrial pressure down. Indeed, the condition of these patients is often remarkably stable despite triple-valve disease. 20 Valve replacement for acute valve failure is an altogether different matter. The effects of sudden aortic or mitral regurgitation may be catastrophic because the left ventricle is not dilated, but the results of prompt surgical correction are particularly good for just the same reason. Degenerative disease of the mitral valve with lengthening or rupture of mitral chordae is now the most common cause of severe mitral regurgitation of acute or subacute onset. Though the patients may be old, sometimes with contributory hypertension or rheumatoid arthritis, the results tend to be much better than after surgery for chronic disease. The results of surgery for acute aortic regurgitation are equally pleasing, though repair of the valve is never possible. Furthermore, because the usual indication is infective endocarditis there may be local difficulties with a higher incidence ofpostoperative paravalvular leak and mechanical haemolysis.
The threat of thromboembolism makes long-term anticoagulant treatment mandatory after replacement with mechanical prostheses. Anticoagulants reduce but do not remove the risk, which is between 3% and 6% each patientyear'0; the risk is greatest in the first year and lower for subsequent years if the first year is uncomplicated. Any benefit from antithrombotic treatment with antiplatelet drugs when used in conjunction with anticoagulants has yet to be proved; they are probably ineffective when given on their own. Tilting-disc prostheses occasionally thrombose, an unpleasant complication which may be related to use of an oversized prosthesis with impedance of free movement or to failure of the patient to take anticoagulants. Nevertheless, even if we do not need to set our sights so high the British do seem to have a curiously apathetic attitude towards measles vaccination. However one calculates the costbenefit equations it must still make practical sense to raise the present measles vaccination rate at least to the 80% or so attained for diphtheria, tetanus, and polio vaccination. The belief'0 that the public acceptance of all vaccines dropped as a result of the whooping-cough controversy is, in fact, mistaken and should not be allowed to excuse our poor vaccination rate for measles. The national vaccination rates for diphtheria, tetanus, and polio have not fallen." Moreover, rates only slightly lower than for diphtheria, tetanus, and polio have been attained for measles vaccination by one highly efficient area health authority,'2 even though their rates of pertussis vaccination fell. The reputation of measles vaccine may still be suffering from the problems caused by side effects and efficacy of the early measles vaccines; it has never really recovered from the loss of impetus that resulted.
Measles vaccination rates can be improved in several ways. One practical step is the use of computers, which have been shown" 13 to be valuable as an aid to vaccine administration. The poor reputation that this excellent vaccine has among mothers,'4 health visitors, clinics, and family doctors'5 16 (many of whom also, erroneously,'l7 see measles as an innocuous and inevitable infection) suggests that some vigorous health education is required. Selective immunisation'8 is clearly not the answer.'9 An integral part of the success of the United States towards eliminating measles has been the enforcement of laws requiring immunisation against measles before school entry.20 The Netherlands,2' however, has achieved a measles
